Literature DB >> 2096430

[Familial hypobetalipoproteinemia. Familial study of 4 cases].

G Gay1, M Pessah, M E Bouma, J F Roche, J P Aymard, I Beucler, L P Aggerbeck, R Infante.   

Abstract

A familial study of four cases with hypobetalipoproteinemia is reported. Three members are heterozygous and one is homozygous. This congenital fat malabsorption in homozygous state is commonly associated with an absence of serum apoprotein B and LDL. Neuromuscular and ophthalmological signs are absent in this case. The major role of upper digestive endoscopy in the diagnostic procedure is emphasized. Histochemical and immunoenzymatic stains of enterocytes and intestinal organ culture show defective synthesis apo B in the homozygous patient. Studies of DNA polymorphism in the homozygous patient have shown that the apo B gene doesn't certain major insertions or deletions. These results are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2096430     DOI: 10.1016/s0248-8663(05)80857-4

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Liver fibrosis in a patient with familial homozygous hypobetalipoproteinaemia: possible role of vitamin supplementation.

Authors:  J Y Scoazec; M E Bouma; J F Roche; D Blache; N Verthier; G Feldmann; G Gay
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

2.  STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis.

Authors:  Hongyan Qi; Zhiyi Yang; Chujun Dai; Runan Wang; Xinxin Ke; Shuilian Zhang; Xueping Xiang; Kailin Chen; Chen Li; Jindan Luo; Jimin Shao; Jing Shen
Journal:  Oncogenesis       Date:  2020-02-10       Impact factor: 7.485

3.  Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.

Authors:  Mu-Su Pan; Hui Wang; Kamar Hasan Ansari; Xin-Ping Li; Wei Sun; Yue-Zu Fan
Journal:  J Exp Clin Cancer Res       Date:  2020-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.